M. Kastrinaki

发表

Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF).

D. Spandidos, N. Siafakas, G. Soufla, 2010, Respiratory medicine.

Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile.

H. Papadaki, P. Charbord, M. Kastrinaki, 2008, Tissue engineering. Part C, Methods.

Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP

D. Spandidos, A. Proklou, G. Soufla, 2012, Journal of Inflammation.

Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes

H. Papadaki, C. Pontikoglou, M. Kastrinaki, 2013, Clinical & developmental immunology.

Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.

P. Katonis, H. Papadaki, C. Pontikoglou, 2011, Stem cells and development.

Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.

C. Mamalaki, K. Giannikou, H. Papadaki, 2010, Stem cells and development.

Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications.

H. Papadaki, M. Kastrinaki, 2009, Current stem cell research & therapy.

Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis

S. Lehmann, J. Ringe, C. Jorgensen, 2007, Annals of the rheumatic diseases.

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

H. Papadaki, C. Pontikoglou, M. Kastrinaki, 2013, Current stem cell research & therapy.

Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.

I. Kotsianidis, H. Papadaki, C. Pontikoglou, 2014, Stem cells and development.

Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia

M. Klontzas, H. Papadaki, M. Kastrinaki, 2012, Haematologica.

Impaired Wnt-Pathway Signalling and Reduced Expression of Senescence-Associated Markers in Bone Marrow Mesenchymal Stem Cells of Patients with Myelodysplastic Syndromes

H. Papadaki, C. Pontikoglou, M. Kastrinaki, 2011 .

Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.

H. Papadaki, C. Pontikoglou, M. Kastrinaki, 2011, Current stem cell research & therapy.

Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors

V. Pachnis, D. Karagogeos, D. Stamataki, 2001, FEBS letters.

Isolation of the human MOX2 homeobox gene and localization to chromosome 7p22.1-p21.3.

W. Modi, V. Pachnis, D. Karagogeos, 1995, Genomics.

Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

P. Katonis, G. Pangalis, K. Alpantaki, 2012, Stem cells and development.

Microtubule‐interacting drugs induce moderate and reversible damage to human bone marrow mesenchymal stem cells

H. Papadaki, M. Kastrinaki, H. Polioudaki, 2009, Cell proliferation.